Focus Financial Network’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,843
Closed -$218K 712
2023
Q3
$218K Sell
7,843
-1,334
-15% -$43.6K 0.01% 541
2023
Q2
$313K Sell
9,177
-229
-2% -$7.2K 0.02% 456
2023
Q1
$283K Sell
9,406
-857
-8% -$26.6K 0.02% 462
2022
Q4
$290K Sell
10,263
-1,278
-11% -$40.6K 0.02% 379
2022
Q3
$379K Buy
11,541
+99
+0.9% +$3.63K 0.03% 331
2022
Q2
$360K Buy
11,442
+528
+5% +$18.5K 0.03% 350
2022
Q1
$501K Sell
10,914
-9,613
-47% -$458K 0.03% 302
2021
Q4
$1.26M Sell
20,527
-9,736
-32% -$673K 0.18% 118
2021
Q3
$2.26M Sell
30,263
-872
-3% -$73.2K 0.3% 85
2021
Q2
$2.88M Buy
31,135
+526
+2% +$44.7K 0.38% 67
2021
Q1
$2.72M Buy
30,609
+16,157
+112% +$1.6M 0.32% 74
2020
Q4
$1.35M Buy
14,452
+8,124
+128% +$647K 0.12% 150
2020
Q3
$403K Buy
6,328
+2,046
+48% +$120K 0.04% 290
2020
Q2
$223K Buy
+4,282
New +$184K 0.02% 358

Other funds holding ARKG

Focus Financial Network's ARKG Position: Q4 2023 in Review

Focus Financial Network sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 7,843 shares — an estimated $218K sold.

Focus Financial Network first reported a position in ARKG in Q2 2020 and held it in 14 quarters. The position peaked at $2.88M in Q2 2021. 298 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

  • Focus Financial Network reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
  • Focus Financial Network sold 7,843 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $218K.
  • Focus Financial Network first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 14 quarters.
  • Focus Financial Network's ARK Genomic Revolution ETF position peaked at $2.88M in Q2 2021.
  • 298 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Focus Financial Network's 13F filing for Q4 2023, filed 12 Feb 2024.